BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) for the treatment of adult patients with ...
A Harvard researcher whose examination of Tylenol’s effects on pregnant women underpinned Donald Trump’s warning to expectant mothers to avoid the drug was once paid $US150,000 ($A227,000) to give ...
A world-first study into how cannabis impacts egg production has found it may cause chromosomal defects, prompting a warning ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive ...
Enterprise data governance is the foundation for safe, scalable AI that transforms underwriting, claims, and distribution.
OpenAI is building five more data centers in the United States as part of the Stargate project. These will be located in ...
Over the past week, regulatory updates spanned approvals, safety statements and policy shifts. The FDA authorized imlunestrant for ESR1-mutated advanced breast cancer, while Australia’s TGA reversed ...
The world is rapidly deploying a new generation of technologies significantly impacting electricity. Continuous monitoring of ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher ...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback